Literature DB >> 1332016

Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain.

L P Davies1, C A Drew, P Duffield, G A Johnston, D D Jamieson.   

Abstract

Kava, an intoxicating beverage prepared from the pepper plant Piper methysticum, is widely consumed by the indigenous peoples in the islands of the South Pacific. As the first of a series of studies on the neuropharmacological interactions of kava with CNS receptors we tested purified pyrones and kava resin for activity on GABA and benzodiazepine binding sites in rat and mouse brain membranes. Only weak activity was observed on GABAA binding sites in washed synaptosomal membranes prepared from rat brain and this was abolished by extraction of the membranes with Triton X-100, suggesting that lipid soluble components were involved. No effects were observed on GABAB binding sites in rat brain membranes in vitro. Kava resin and pyrones exerted some weak effects on benzodiazepine binding in vitro but this did not correlate with pharmacological activity. In addition, in ex vivo studies, no effects were observed on [3H]diazepam binding to brain membranes prepared from mice in which selected kava constituents were injected intraperitoneally, whereas similarly administered diazepam (5 mg/kg) inhibited [3H]diazepam binding by greater than 95%. Similar lack of activity was observed in in vivo binding studies; injection of kava resin failed to influence the CNS binding of the benzodiazepine-receptor ligand [3H]Ro15-1788 injected into mice prior to sacrifice. The pharmacological activities of kava resin and pyrones do not appear to be explained by any significant interaction with GABA or benzodiazepine binding sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332016     DOI: 10.1111/j.1600-0773.1992.tb00530.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  9 in total

1.  Differential regulation of calcium signalling pathways by components of Piper methysticum ('Awa).

Authors:  L M N Shimoda; A Showman; J D Baker; I Lange; D L Koomoa; A J Stokes; R P Borris; H Turner
Journal:  Phytother Res       Date:  2015-01-30       Impact factor: 5.878

2.  Kava and dopamine antagonism.

Authors:  L Schelosky; C Raffauf; K Jendroska; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

Review 3.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.

Authors:  A Jussofie; A Schmiz; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.

Authors:  Kennon M Garrett; Garo Basmadjian; Ikhlas A Khan; Brian T Schaneberg; Thomas W Seale
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 6.  Interaction of Plant Extracts with Central Nervous System Receptors.

Authors:  Kenneth Lundstrom; Huyen Thanh Pham; Long Doan Dinh
Journal:  Medicines (Basel)       Date:  2017-02-23

7.  Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

Authors:  Han Chow Chua; Emilie T H Christensen; Kirsten Hoestgaard-Jensen; Leonny Y Hartiadi; Iqbal Ramzan; Anders A Jensen; Nathan L Absalom; Mary Chebib
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

8.  Amides from Piper capense with CNS activity - a preliminary SAR analysis.

Authors:  Mikael E Pedersen; Bjørn Metzler; Gary I Stafford; Johannes van Staden; Anna K Jäger; Hasse B Rasmussen
Journal:  Molecules       Date:  2009-09-25       Impact factor: 4.411

Review 9.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.